摘要
Current clinical factors for screening candidates that might benefit from adjuvant chemotherapy in colon cancer are inadequate. Tumor microenvironment, especially the stromal components, has the potential to determine treatment response. However, clinical translation of the tumor-associated stromal characterization into a practical biomarker for helping treatment decision has not been established. Using machine learning, we established a novel 31-gene signature, called stromal cell infiltration intensity score (SIIS), to distinguish patients characterized by the enrichment of abundant stromal cells in five colon cancer datasets from GEO (N = 990). Patients with high-SIIS were at higher risk for recurrence and mortality, and could not benefit from adjuvant chemotherapy due to their intrinsic drug resistance; however, the opposite was reported for patients with low-SIIS. The role of SIIS in detection of patients with high stromal cell infiltration and reduced drug efficiency was consistently validated in the TCGA-COAD cohort (N = 382), Sun Yat-sen University Cancer Center cohort (N = 30), and could also be observed in TCGA pan-cancer settings (N = 4898) and four independent immunotherapy cohorts (N = 467). Based on multi-omics data analysis and the CRISPR library screen, we reported that lack of gene mutation, hypomethylation in ADCY4 promoter region, activation of WNT-PCP pathway and SIAH2-GPX3 axis were potential mechanisms responsible for the chemoresistance of patients within high-SIIS group. Our findings demonstrated that SIIS provide an important reference for those making treatment decisions for such special patients. (c) 2022 Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
学科与关键词
- A stromal and immune cell infiltration-based score model predicts prognosis and chemotherapy effect in colorectal cancerLuo, Qingqing; He, Feng*; Cao, Jie*International Immunopharmacology, 2021, 99: 107940.被引 4
- Identification of Prognostic Gene Signatures by Developing a scRNA-Seq-Based Integration Approach to Predict Recurrence and Chemotherapy Benefit in Stage II-III Colorectal CancerWang, Zixuan; Xing, Kaiyuan; Zhang, Bo; Zhang, Yanru; Chai, Tengyue; Geng, Jingkai; Qin, Xuexue; Zhang, Xinxin*; Xu, Chaohan*INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23(20): 12460.被引 1
- Expression pattern of secretory-cell-related transcriptional signatures in colon adenocarcinomas defines tumor microenvironment characteristics and correlates with clinical outcomesZhou, Rui; Li, Lingbo; Xi, Shaoyan; Zhang, Yue; Liu, Zhihong; Zeng, Dongqiang; Sun, Huiying; Wu, Jianhua; Wang, Ling; Shi, Min; Bin, Jianping; Liao, Yulin; Liao, Wangjun*Molecular Oncology, 2023, 17(3): 499-517.被引 1
